Skip to content

Short Term Comparative Assessment of MTA and Biodentine in Complete Pulpotomy for Symptomatic Irreversible Pulpitis

Short Term Outcome of Complete Pulpotomy Using MTA vs Biodentine in Symptomatic Irreversible Pulpitis - A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07483788
Enrollment
60
Registered
2026-03-19
Start date
2024-11-02
Completion date
2026-07-31
Last updated
2026-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic Irreversible Pulpitis (SIP)

Keywords

Symptomatic Irreversible Pulpitis, Complete pulpotomy

Brief summary

All Patients coming to the Operative Dentistry Department (DIDC-DUHS) with complain of pain in posterior teeth will be invited to participate. The treatment will be done by one dentist. Patient's medical and dental history will be recorded, and tooth will be checked for swelling, sensitivity, cavity type, and loosening of tooth. Special tests like the cold test, electric pulp test, and an X-ray will help assess the tooth's condition. Patient will also be asked to rate pain from 1-10. Before starting the treatment, the procedure will be explained to patient in detail, and written consent will be taken. The treatment will be done in two visits by one dentist. Patient will be given an injection to make tooth pain-free so that patient does not feel any discomfort during the treatment and the area will be kept clean using a rubber sheet. The dentist will remove the hole in tooth and remove the infected soft part of tooth and stop the bleeding. Then one of the two materials will be placed inside the tooth. A temporary filling will be placed first, and patient will come the next day for the final filling. An X-ray will be taken to check the result. If patient feel pain, may take ibuprofen (400 mg) as needed, and if the pain continues, please contact the dentist. Patient will be called for follow-ups after 1 day, 1 week, 1 month, and 3 months to make sure the tooth is healing properly.

Interventions

Pulpotomy performed using Mineral Trioxide Aggregate (MTA)

Sponsors

Dow University of Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

Teeth of generally healthy patients having following criteria will be included: 1. Age between 18-40 years of both males and females 2. Carious exposed maxillary and mandibular molars teeth 3. Moderate to severe pain (VAS 4-10) 4. Diagnosed with Symptomatic irreversible pulpitis on cold test and Electric pulp test (EPT) 5. Periapical index of 1 6. Hemostasis is achieved within 10 mins after full pulpotomy

Exclusion criteria

Teeth of generally healthy patients having following criteria will be excluded: 1. Any traumatic injury 2. Non-restorable carious lesion 3. Immature or Open apices of roots 4. Internal or external Resorption 5. Calcified canals

Design outcomes

Primary

MeasureTime frameDescription
Short term outcome of complete pulpotomy using MTA vs Biodentine in Symptomatic Irreversible Pulpitis- A Randomized Controlled Trial3 monthsClinical outcome measure through Electric pulp testing (EPT) and radiographic outcome measure through Periapical index (PAI)

Countries

Pakistan

Contacts

CONTACTDr Khadija Zubair, Postgraduate trainee- FCPS
khadija.zubair21@yahoo.com03363605145
PRINCIPAL_INVESTIGATORDr Khadija Zubair, Postgraduate Trainee- FCPS

Dow University of Health Sciences

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026